PharmacoGx: An R package for analysis of large pharmacogenomic datasets

Bioinformatics

Volumn 32, Issue 8, 2016, Pages 1244-1246

  Smirnov, Petr ^a   Safikhani, Zhaleh ^a,b   El Hachem, Nehme ^c   Wang, Dong ^a   She, Adrian ^a   Olsen, Catharina ^a,d,e   Freeman, Mark ^a   Selby, Heather ^f,g   Gendoo, Deena M A ^a,b   Grossmann, Patrick ^f   Beck, Andrew H ^h   Aerts, Hugo J W L ^f   Lupien, Mathieu ^a,b,i   Goldenberg, Anna ^j,k   Haibe Kains, Benjamin ^a,b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^d Interuniversity Institute of Bioinformatics in Brussels (IB)2   (Belgium)

^e UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^f HARVARD MEDICAL SCHOOL   (United States)

^g BOSTON UNIVERSITY   (United States)

^h BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

ⁱ ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

^j HOSPITAL FOR SICK CHILDREN   (Canada)

^k UNIVERSITY OF TORONTO   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTER LANGUAGE; GENOMICS; HUMAN; NEOPLASM; PHARMACOGENETICS; SOFTWARE;

GENOMICS; HUMANS; NEOPLASMS; PHARMACOGENETICS; PROGRAMMING LANGUAGES; SOFTWARE;

EID: 84966550886     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btv723     Document Type: Article

References (9)

1. Barretina, J. et al. (2012) The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature, 483, 603-607.
2. Caiment, F. et al. (2013) Assessing compound carcinogenicity in vitro using connectivity mapping. Carcinogenesis, 35, 201-207.
3. Dai, M. et al. (2005) Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res., 33, e175.
4. Garnett, M.J. et al. (2012) Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature, 483, 570-575.
5. Glaser, K.B. et al. (2003) Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines. Mol. Cancer Therap., 2, 151-163.
6. Haibe-Kains, B. et al. (2013) Inconsistency in large pharmacogenomic studies. Nature, 504, 389-393.
7. Hatzis, C. et al. (2014) Enhancing reproducibility in cancer drug screening: how do we move forward? Cancer Res., 74, 4016-4023.
8. Lamb, J. et al. (2006) The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease. Science, 313, 1929-1935.
9. Sirota, M. et al. (2011) Discovery and preclinical validation of drug indications using compendia of public gene expression data. Sci. Transl. Med., 3, 9677-9677.